metastasis-directed therapy | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

96,193 results for “metastasis-directed therapy”

Meta-Analysis Confirms Metastasis-Directed Therapy Benefits for Oligometastatic Prostate Cancer

Metastasis-Directed Radiotherapy Shows Durable Disease Control in Oligometastatic Renal Cell Carcinoma Without Systemic Therapy

AI Biomarker Predicts Survival and Treatment Response in Oligometastatic Prostate Cancer

MD Anderson Reports Breakthrough in Metastatic Prostate Cancer Treatment with Targeted Therapy

Myriad's Precise MRD Test Shows Promise in Detecting Circulating Tumor DNA in Oligometastatic Renal Cell Carcinoma

Elective Nodal Radiotherapy Shows Superior Metastasis-Free Survival in Oligorecurrent Prostate Cancer

Combination Therapy Shows Promise in Oligometastatic Prostate Cancer

RADIOSA Trial Shows ADT Addition to SBRT Improves Progression-Free Survival in Oligorecurrent Prostate Cancer

VA STARPORT Network Tackles Challenges in Oligometastatic Prostate Cancer Trial

Metastatic Patterns and Treatment Response in Prostate Cancer: New Insights into Disease Progression

Page 1 of 2002